v3.26.1
CONDENSED BALANCE SHEETS - USD ($)
Feb. 28, 2026
Aug. 31, 2025
Current Asset    
Cash $ 593,400 $ 0
Total Current Asset 593,400 0
Non-current Assets    
Cash held in Trust Account 100,112,500 0
Deferred offering costs 0 100,000
Total Non-current Assets 100,112,500 100,000
Total Assets 100,705,900 100,000
Current Liabilities    
Accrued expenses 68,334 15,000
Promissory Note - Related party 0 93,511
Due to Sponsor 18,796 0
Over-allotment option liability 127,200 0
Total Current Liabilities 214,330 108,511
Total Liabilities 214,330 108,511
Commitments and Contingencies – (see Note 6) 0  
Ordinary shares, $0.0001 par value, 500,000,000 shares authorized, 10,000,000 shares subject to possible redemption 100,112,500 0
Shareholders’ Equity (Deficit)    
Ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 4,388,303 and 3,833,333 shares issued and outstanding (excluding 10,000,000 shares subject to possible redemption) as of February 28, 2026 and August 31, 2025, respectively(1)(2) [1],[2] 439 383
Additional paid-in capital 524,817 24,617
Accumulated deficit (146,186) (33,511)
Total Shareholders’ Equity (Deficit) 379,070 (8,511)
Total Liabilities, Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit) $ 100,705,900 $ 100,000
[1] Includes an aggregate of up to 500,000 ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 7).
[2] Shares have been retroactively restated to reflect founder share subscription agreement.